We are live on
!
Find out more
PD
Point72 (DIFC) Portfolio holdings
AUM
$1.53B
1-Year Est. Return
15.83%
This Fund
S&P 500
This Quarter
Est. Return
-3.74%
1 Year Est. Return
+15.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.44B
AUM Growth
-$284M
(-10%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
11.4%
Holding
2,163
New
689
Increased
397
Reduced
522
Closed
547
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$39.6M |
| 2 |
Boston Scientific
BSX
|
+$17.5M |
| 3 |
Edwards Lifesciences
EW
|
+$16.2M |
| 4 |
CSX Corp
CSX
|
+$14M |
| 5 |
Agilent Technologies
A
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$18.1M |
| 2 |
Amazon
AMZN
|
+$17.6M |
| 3 |
Comcast
CMCSA
|
+$17.4M |
| 4 |
KKR & Co
KKR
|
+$15.8M |
| 5 |
McKesson
MCK
|
+$14.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.78% |
| 2 | Technology | 9.17% |
| 3 | Industrials | 4.5% |
| 4 | Financials | 3.81% |
| 5 | Consumer Discretionary | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CON
1301
Concentra Group Holdings
CON
$4.06B
| $28.4K | ﹤0.01% |
+1,310
| New | +$28.8K |
|
1302
National Health Investors
NHI
$3.68B
| $28.3K | ﹤0.01% |
383
-349
| -48% | -$24.6K |
|
|
ALEX
1303
DELISTED
Alexander & Baldwin
ALEX
| $28.3K | ﹤0.01% |
1,640
+91
| +6% | +$1.61K |
|
|
SWTX
1304
DELISTED
SpringWorks Therapeutics
SWTX
| $27.6K | ﹤0.01% |
+626
| New | +$28.8K |
|
1305
Anterix
ATEX
$1.87B
| $27.1K | ﹤0.01% |
+740
| New | +$25.5K |
|
1306
PUT
State Street
STT
$50.5B
| $26.9K | ﹤0.01% |
300
-100
| -25% | -$9.55K |
|
1307
Cooper-Standard Automotive
CPS
$538M
| $26.8K | ﹤0.01% |
1,747
+1,357
| +348% | +$20.3K |
|
1308
CALL
T-Mobile US
TMUS
$190B
| $26.7K | ﹤0.01% |
100
-3,000
| -97% | -$739K |
|
|
STKL
1309
DELISTED
SunOpta
STKL
| $26.6K | ﹤0.01% |
5,474
+5,392
| +6,576% | +$35.9K |
|
1310
CALL
Applovin
APP
$136B
| $26.5K | ﹤0.01% |
+100
| New | +$34.5K |
|
1311
Cytek Biosciences
CTKB
$557M
| $26.3K | ﹤0.01% |
+6,570
| New | +$34K |
|
1312
Adeia
ADEA
$3.07B
| $26.3K | ﹤0.01% |
+1,991
| New | +$27.7K |
|
1313
Progyny
PGNY
$2.47B
| $26.2K | ﹤0.01% |
+1,174
| New | +$25.3K |
|
1314
PUT
CBRE Group
CBRE
$43B
| $26.2K | ﹤0.01% |
200
-500
| -71% | -$67.9K |
|
1315
Real Brokerage
REAX
$355M
| $26K | ﹤0.01% |
+6,405
| New | +$30.4K |
|
1316
BRC Inc
BRCC
$123M
| $25.6K | ﹤0.01% |
12,250
-5,508
| -31% | -$14K |
|
1317
Playtika
PLTK
$1.54B
| $25.5K | ﹤0.01% |
4,940
-5,914
| -54% | -$37.1K |
|
1318
Delcath Systems
DCTH
$450M
| $25.5K | ﹤0.01% |
2,000
+300
| +18% | +$4.26K |
|
1319
Theravance Biopharma
TBPH
$874M
| $25.4K | ﹤0.01% |
+2,839
| New | +$26.4K |
|
1320
Metropolitan Bank Holding Corp
MCB
$1.15B
| $25.3K | ﹤0.01% |
+452
| New | +$26.9K |
|
1321
NWPX Infrastructure Inc
NWPX
$1.23B
| $24.9K | ﹤0.01% |
602
-230
| -28% | -$10.7K |
|
1322
ClearPoint Neuro
CLPT
$461M
| $24.8K | ﹤0.01% |
2,089
+510
| +32% | +$7.93K |
|
1323
Prosperity Bancshares
PB
$9.02B
| $24.8K | ﹤0.01% |
+347
| New | +$26.3K |
|
|
VRE
1324
DELISTED
Veris Residential
VRE
| $24.7K | ﹤0.01% |
1,460
-5,166
| -78% | -$83.5K |
|
1325
Hyster-Yale Materials Handling
HY
$628M
| $24.5K | ﹤0.01% |
590
-145
| -20% | -$7.21K |
|
Similar funds
HT
SIMG
4CM
SAM
CCB
SFI
P
FSC
Point72 (DIFC)'s Q1 2025 Portfolio in Review
As of Q1 2025, Point72 (DIFC) held 2,163 positions worth $2.44B, down 10% from $2.72B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Point72 (DIFC) withdrew a net $174M in Q1 2025, closing 547 positions and reducing 522 holdings. Its most notable exit was Amazon, an estimated $17.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.
Against the trend, Point72 (DIFC) opened a new position in Meta Platforms (Facebook) worth $35.4M.
- Point72 (DIFC)'s largest Q1 2025 buy was Meta Platforms (Facebook): 61,365 shares worth $35.4M.
- Point72 (DIFC) added most to Boston Scientific in Q1 2025, an estimated $17.5M increase.
- Point72 (DIFC)'s biggest Q1 2025 reduction was Salesforce, cutting an estimated $18.1M.
- Point72 (DIFC) fully exited Amazon in Q1 2025, selling an estimated $17.6M.
- Point72 (DIFC)'s ten largest holdings make up 11% of its $2.44B portfolio in Q1 2025.
- Point72 (DIFC) opened 689 new positions and closed 547 in Q1 2025.
- Point72 (DIFC)'s portfolio value fell 10% quarter-over-quarter to $2.44B.
Based on Point72 (DIFC)'s 13F filing for Q1 2025, filed 15 May 2025.